Improving inhaler use in children with asthma
OUtcome Following Tailored Education and Retraining: Studying Performance and Adherence in ChildrEn and Young People With Asthma: a Randomised Feasibility Study
This study is testing if giving kids with asthma extra education about using their inhalers can help them use their medication correctly and manage their asthma better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 6 Years to 18 Years |
| Sex | All |
| Sponsor | University Hospitals of North Midlands NHS Trust Academic / other |
| Locations | 1 site (Stoke-on-Trent, Staffordshire) |
| Trial ID | NCT05366309 on ClinicalTrials.gov |
What this trial studies
This study focuses on children aged 6-18 years who have been diagnosed with asthma and are attending secondary care. It aims to improve adherence to inhaler medication by providing tailored education alongside standard care education. The study will assess the performance of children using spacer devices for inhaled medications, addressing common issues of underuse and overuse that lead to poor asthma control. Participants will undergo lung function tests and exhaled nitric oxide measurements to evaluate their asthma management.
Who should consider this trial
Good fit: Ideal candidates are children aged 6-18 years with a diagnosis of asthma who are able to use a spacer device for their inhaler medication.
Not a fit: Patients with significant co-existing respiratory diseases or those currently participating in other clinical trials may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better asthma control in children, reducing the frequency of asthma attacks and improving overall quality of life.
How similar studies have performed: Other studies have shown that tailored education can improve medication adherence in asthma patients, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 6-18 years; * Attending secondary care with a diagnosis of asthma; * Willing and able to give fully informed consent, or, participants having an acceptable individual capable of giving consent on the participant's behalf (e.g. parent or guardian of a child under 16 years of age); * Able to perform lung function and exhaled nitric oxide measurements; * Take twice-daily preventer medication using a valved holding chamber (spacer device) i.e. inhaled corticosteroid with or without long-acting beta antagonist; * Willing and able to comply with the study procedures. Exclusion Criteria: * Significant co-existing respiratory disease (e.g. cystic fibrosis); * Currently participating in another clinical trial of an investigational medicinal product or medical device; * Non-English speaker where translation facilities are insufficient to guarantee informed consent.
Where this trial is running
Stoke-on-Trent, Staffordshire
- Robert James Bowler — Stoke-on-Trent, Staffordshire, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Will Carroll — Pi
- Study coordinator: Robert Bowler
- Email: robert.bowler@uhnm.nhs.uk
- Phone: 01782
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.